These top 5 stories underscore how 2025 was a year of constant friction at the intersection of public health and political ...

Ryan Haumschild, PharmD, MS, MBA, introduces the faculty and sets the agenda to explore disease background, novel therapies, ...

Panelists discuss how schizophrenia typically evolves through distinct phases—from first-episode psychosis to chronic illness ...

Panelists discuss how relapse is one of the most significant challenges in schizophrenia management, often resulting in ...

Panelists discuss how defining and tracking meaningful real-world outcomes ensures accountability and value in MASH ...

From there, the discussion turns to bispecific antibodies for relapsed/refractory multiple myeloma (RRMM) and the unmet needs ...

Blinatumomab addition to chemotherapy significantly improves survival and reduces relapse in pediatric B-cell acute ...

An immunomodulatory vaccine advancing to phase 3 trials highlights the evolving role of immune system recalibration in cancer treatment. From immunotherapy breakthroughs to early-stage scientific ...

Our top content coverage from the Conference on Retroviruses and Opportunistic Infections (CROI) 2025 highlighted ...

For those and other reasons, targeted oral therapies like Bruton tyrosine kinase inhibitors (BTKis) and the BCL-2 inhibitor ...

Ruxolitinib cream demonstrated favorable safety and efficacy in pediatric atopic dermatitis, highlighting JAK inhibitors' ...

AI's role in early cancer detection and patient outcome improvement is significant, with tools evaluated for utility and ...